Article
British Columbia, Canada-Optos, an ophthalmic device company based in Marlborough, MA, is expanding into Canada with sales of its diagnostic exam for retinal disease.
Survey reveals gaps in patient awareness of preservative-free glaucoma treatments
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Harrow to enact a 5-year strategic supply and development agreement for triamcinolone acetonide injectable suspension
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Choroidal vascularity index offers insight into eye health after COVID-19 recovery
FDA accepts new drug application for low-dose atropine from Sydnexis